Radiographic enlargement of mandibular canal as first feature of non-Hodgkin's lymphoma

被引:18
作者
Buric, N. [1 ]
Jovanovic, G.
Radovanovic, Z. [2 ]
Buric, M. [3 ]
Tijanic, M.
机构
[1] Univ Nis, Clin Stomatol, Dept Oral & Maxillofacial Surg, Sch Med & Stomatol, Nish 18000, Serbia
[2] Ctr Clin, Inst Radiol, Nish, Serbia
[3] Univ Nis, Sch Med & Stomatol, Dept Orthodont, Nish 18000, Serbia
关键词
non-Hodgkin's lymphoma; mandible; neoplasm; panoramic radiography;
D O I
10.1259/dmfr/16059055
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Non-Hodgkin's lymphoma has the propensity to affect non-lymphoid tissue including oral tissue. Primary non-Hodgkin's lymphoma of the mandible mistreated as chronic periodontitis with diffuse enlargement of the mandibular canal and ice-cold numbness is very rarely described in English medical literature. A 57-year-old patient presented with a painful swelling on the left side of the mandible with a clinically chronic periodontitis associated with ice-cold numbness. A panoramic radiograph showed a diffuse uniform enlargement of the mandibular canal. Histological examination showed that the lesion was a primary intraosseous non-Hodgkin's lymphoma of the mandible. Immunohistochemical examination showed a positive reaction for CD20+, Ki-67+. Seven months after chemotherapy the patient was observed for possible life-threatening propagation of the disease. In conclusion, primary (extra-nodal) non-Hodgkin's lymphoma of the mandible usually clinically presents with bone swelling, teeth mobility and neurological disturbance. Radiographic features presenting as diffuse enlargement of the mandibular canal could be considered as non-Hodgkin's lymphoma. Dentomaxillofacial Radiology (2010) 39, 383-388. doi: 10.1259/dmfr/16059055
引用
收藏
页码:383 / 388
页数:6
相关论文
共 50 条
  • [31] Cladribine in indolent non-Hodgkin's lymphoma
    Sigal, Darren S.
    Saven, Alan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (04) : 535 - 545
  • [32] Molecular remission and non-Hodgkin's lymphoma
    Darby, AJ
    Johnson, PWM
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (03) : 549 - 562
  • [33] Checkpoint Inhibition in Non-Hodgkin's Lymphoma
    Hess, Georg
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (11) : 662 - 672
  • [34] BRAF mutations in non-Hodgkin's lymphoma
    Lee, JW
    Yoo, NJ
    Soung, YH
    Kim, HS
    Park, WS
    Kim, SY
    Lee, JH
    Park, JY
    Cho, YG
    Kim, CJ
    Ko, YH
    Kim, SH
    Nam, SW
    Lee, JY
    Lee, SH
    BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1958 - 1960
  • [35] Non-Hodgkin's lymphoma of the sinonasal tract
    Quraishi, MS
    Bessell, EM
    Clark, D
    Jones, NS
    Bradley, PJ
    LARYNGOSCOPE, 2000, 110 (09) : 1489 - 1492
  • [36] Romidepsin for the treatment of non-Hodgkin's lymphoma
    Yazbeck, Victor Y.
    Grant, Steven
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (07) : 965 - 979
  • [37] Epidemiology of Non-Hodgkin's Lymphoma in India
    Nair, Reena
    Arora, Neeraj
    Mallath, Mohandas K.
    ONCOLOGY, 2016, 91 : 18 - 25
  • [38] The allogeneic effect in non-Hodgkin's lymphoma
    Goldstone, AH
    Kottaridis, PD
    LEUKEMIA & LYMPHOMA, 2003, 44 : S91 - S97
  • [39] Palliative chemotherapy in non-Hodgkin's lymphoma
    Salminen, E
    Nikkanen, V
    Lindholm, L
    ONCOLOGY, 1997, 54 (02) : 108 - 111
  • [40] Primary pulmonary non-Hodgkin's lymphoma
    Kim, JH
    Lee, SH
    Park, J
    Kim, HY
    Lee, SI
    Park, JO
    Kim, K
    Kim, WS
    Jung, CW
    Park, YS
    Im, YH
    Kang, WK
    Lee, MH
    Park, K
    Han, JH
    Ko, YH
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (09) : 510 - 514